Evidence map›Paper›PMID 29476251›Full record

ArticleJournal of gastroenterology2018

Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey.

Satoru Joshita, Kaname Yoshizawa, Takeji Umemura, Hiromasa Ohira, Atsushi Takahashi, Kenichi Harada, Nguyen Canh Hiep, Koichi Tsuneyama, Masayoshi Kage, Masayuki Nakano and 11 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. [Diagnosis of Autoimmune Hepatitis].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Recent updates on the management of autoimmune hepatitis.Clinical and molecular hepatology · 2021
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 1 country.

Satoru JoshitaDepartment of Gastroenterology, National Hospital Organization, Shinshu Ueda Medical Center, 1-27-21 Midorigaoka, Ueda, 386-8610, Japan.
Kaname YoshizawaDepartment of Gastroenterology, National Hospital Organization, Shinshu Ueda Medical Center, 1-27-21 Midorigaoka, Ueda, 386-8610, Japan. k.yoshizawa@nagano-hosp.go.jp.ORCID http://orcid.org/0000-0002-8468-7131
Takeji UmemuraDepartment of Medicine, Division of Gastroenterology and Hepatology, Shinshu University School of Medicine, Matsumoto, Japan.
Hiromasa OhiraDepartment of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Atsushi TakahashiDepartment of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Kenichi HaradaDepartment of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Nguyen Canh HiepDepartment of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Koichi TsuneyamaDepartment of Pathology Lab. Med., Tokushima University Graduate School, Tokushima, Japan.
Masayoshi KageKurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.
Masayuki NakanoDivision of Diagnostic Pathology, Shonan Fujisawa Tokushukai Hospital, Fujisawa, Japan.
Jong-Hon KangCenter for Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan.
Kazuhiko KoikeDepartment of Gastroenterology and Hepatology, The Third Hospital of Jikei University School of Medicine, Tokyo, Japan.
Mikio ZeniyaDepartment of Gastroenterology and Hepatology, The Third Hospital of Jikei University School of Medicine, Tokyo, Japan.
Tetsuya YasunakaDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan.
Akinobu TakakiDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan.
Takuji TorimuraDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Masanori AbeDepartment of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Tōon, Japan.
Osamu YokosukaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Atsushi TanakaDepartment of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Hajime TakikawaDepartment of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Japan Autoimmune Hepatitis Study Group (JAIHSG)
Kurume University · JPJikei University School of Medicine · JPKanazawa University · JPChiba University · JPFukushima Medical University · JPShinshu University · JPTeikyo University · JPNational Hospital Organization · JPOkayama University · JPTeine Keijinkai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutoimmune hepatitis (AIH) is characterized by progressive inflammation and necrosis of hepatocytes and eventually leads to a variety of phenotypes, including acute liver dysfunction, chronic progressive liver disease, and fulminant hepatic failure. Although the precise mechanisms of AIH are unknown, environmental factors may trigger disease onset in genetically predisposed individuals. Patients with the recently established entity of AIH with acute presentation often display atypical clinical features that mimic those of acute hepatitis forms even though AIH is categorized as a chronic liver disease. The aim of this study was to identify the precise clinical features of AIH with acute presentation.

methodsEighty-six AIH patients with acute presentation were retrospectively enrolled from facilities across Japan and analyzed for clinical features, histopathological findings, and disease outcomes.

resultsSeventy-five patients were female and 11 were male. Patient age ranged from adolescent to over 80 years old, with a median age of 55 years. Median alanine transaminase (ALT) was 776 U/L and median immunoglobulin G (IgG) was 1671 mg/dL. There were no significant differences between genders in terms of ALT (P = 0.27) or IgG (P = 0.51). The number of patients without and with histopathological fibrosis was 29 and 57, respectively. The patients with fibrosis were significantly older than those without (P = 0.015), but no other differences in clinical or histopathological findings were observed. Moreover, antinuclear antibody (ANA)-positive (defined as × 40, N = 63) and -negative (N = 23) patients showed no significant differences in clinical or histopathological findings or disease outcomes. Twenty-five patients experienced disease relapse and two patients died during the study period. ALP ≥ 500 U/L [odds ratio (OR) 3.20; 95% confidence interval (CI) 1.12-9.10; P < 0.030] and GGT ≥ 200 U/L (OR 2.98; 95% CI 1.01-8.77; P = 0.047) were identified as independent risk factors of disease relapse.

conclusionsAIH with acute presentation is a newly recognized disease entity for which diagnostic hallmarks, such as ALT, fibrosis, and ANA, are needed. Further investigation is also required on the mechanisms of this disorder. Clinicians should be mindful of disease relapse during patient care.

Indexed as

Hospitals, UniversityAcute DiseaseAdolescentAdultAgedAged, 80 and overAlanine TransaminaseAlkaline PhosphataseAntibodies, AntinuclearFemaleFibrosisgamma-GlutamyltransferaseHepatitis, AutoimmuneHepatocytesHumansImmunoglobulin GAlanine TransaminaseAlkaline PhosphataseAntibodies, Antinucleargamma-GlutamyltransferaseImmunoglobulin GPrednisoloneAntinuclear antibodyAutoimmune hepatitisFibrosisHistopathologyImmunoglobulin G

Identifiers

PMID29476251
OpenAlexW2791842426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.